News

Chronic inflammation underlies a surprisingly wide range of diagnoses: autoimmune flares, unexplained fatigue, hormonal disruption, stubborn weight gain. People who've cycled through standard appointments without lasting relief will find that functional medicine clinics in Denver for a personalized approach...

METiS TechBio has announced a strategic collaboration with Eli Lilly and Company to research and develop next-generation lipid nanoparticle (LNP)-based delivery solutions, leveraging METiS's proprietary AI-driven platform to enable precise, tissue-specific delivery of therapeutic modalities. Under the terms of the...

Eli Lilly and Mubadala Bio have signed a formal agreement to develop local pharmaceutical packaging and logistics capabilities for Lilly's GLP-1 medicines in Abu Dhabi, with the collaboration anchored by a dedicated 125,000 sqm site at Khalifa Economic Zones...

Every pipeline, from a Phase II protocol to a hospital pharmacy formulary, runs on licensed people. Right now those people are hard to find. ManpowerGroup’s 2026 Talent Shortage Survey, which covered more than 39,000 employers in 41 countries, found...

Medical device cybersecurity has become too important to treat as a final-stage documentation exercise. Connected devices, software-enabled products, cloud platforms, wireless interfaces, and remote monitoring capabilities can create security risks that extend far beyond the device itself. Manufacturers must...

Billerud has officially introduced PharmaKraft, a specialized fibre-based packaging material carefully designed for non-sterile dry pharmaceutical applications. This newly developed product utilizes fresh fibre featuring tightly controlled purity characteristics to meet rigorous industry demands. As a notable addition to...

AstraZeneca has inked a billion-dollar AI drug discovery partnership and licensing deal with insitro to identify novel targets and therapies for a range of cardiometabolic diseases. Through this strategic agreement, the organizations will work in tandem to create drugs...